HEALTH BRIEFS: Week of June 23, 2013 - Odessa American
The Medical Center Hospital Diabetes Center Support Group has scheduled a meeting at 5:30 p.m. Tuesday in the Fellowship Hall of Redeemer Lutheran Church, 824 E. 18th St., with parking around the back off of 17th Street. Dr. Craig Spellman, nephrologist with the Texas Tech Health Science Center, will present the program on kidney disease in people with uncontrolled diabetes. Refreshments will also be provided. The meeting is open to all interested people.
Read the full story >>
Related Stories
Molecular Pathology Preceptorship: Unmatched Value and Experience
Ericka Hendrix, PhD, MB(ASCP)CM, Program Director and Associate Professor in the Master of Science in Molecular Pathology program in the School of Health Professions spoke about the program’s preceptorship.
Moseley Named Permian Basin Regional Dean of the Texas Tech University Health Sciences Center School of Nursing
Kelly Moseley, DHSc, R.N., has been named the TTUHSC School of Nursing regional dean in the Permian Basin.
TTUHSC School of Nursing to Celebrate New YWCA Location
Community members in central Lubbock now have access to health care services and prenatal programs at one location inside the YWCA.
Recent Stories
New Permian Basin Chair Seeks to Develop International Hub for Rural Psychiatry
Rajendra Badgaiyan, M.D., joined the Texas Tech University Health Sciences Center (TTUHSC) School of Medicine in November as a professor and Department of Psychiatry chair at the Permian Basin campus.
The ARRIVE Program: Offering a Brighter Future for the IDD Community
The ARRIVE Program provides a supported work context within the TTUHSC Occupational Therapy Department (OTD) for young adults with IDD to gain necessary skills.
Study Focuses on Resistance to Androgen Receptor-Targeted Therapy in Advanced Prostate Cancer
A TTUHSC research team led by Srinivas Nandana, Ph.D., and Manisha Tripathi, Ph.D., from the TTUHSC School of Medicine recently completed a study that focused on uncovering the mechanisms that drive the progression of prostate cancer.